Cancer survival might depend on what time of day you get your treatment, a new study says.
Lung cancer patients who received IV immunotherapy doses earlier in the day tended to live longer, researchers wrote in a study published online Monday in the journal Cancer.
Getting immunotherapy drugs before 3 p.m. was associated with a 52% lower risk of cancer progression and a 63% lower risk of death, the study found.
This could be an inexpensive way to extend survival for cancer patients, said senior researcher Dr. Yongchang Zhang, an associate professor at the Affiliated Cancer Hospital of Xiangya School of Medicine at Central South University in China.
Related
